Other languages Unichem Laboratories Limited NSE India S.E.

Equities

UNICHEMLAB

INE351A01035

Delayed NSE India S.E. Other stock markets 06:02:36 2024-05-14 EDT			5-day change	1st Jan Change
555.4 ^INR	-0.69%		-0.54%	+36.82%

03-29	Unichem Laboratories Limited Announces Board Resignations, Effective March 31, 2024	CI
03-27	Unichem Laboratories Chief Commercial and International Business Development Officer Steps Down	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Unichem Laboratories Limited Announces Board Resignations, Effective March 31, 2024	03-29
Unichem Laboratories Chief Commercial and International Business Development Officer Steps Down	03-27
Unichem Laboratories Limited Announces Resignation of Santosh Mahil as Chief Commercial & International Business Development Officer	03-27
Unichem Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-05
Indian Equities Close Marginally Higher Ahead of IT Earnings	01-11
Unichem Laboratories Limited Receives Anda Approval for Its Doxazosin Tablets USP, 1 Mg, 2 Mg, 4 Mg and 8 Mg	01-11
Unichem Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-01
Ipca Laboratories Limited completed the acquisition of 19.29% stake in Unichem Laboratories Limited for INR 6 billion.	23-09-07
Unichem Laboratories Limited Receives ANDA Approval for its Prasugrel Tablets USP, 5 Mg and 10 Mg from the United States Food and Drug Administration	23-08-29
Unichem Laboratories Limited Announces the Resignation of Dilip Kunkolienkar as Member of the Audit Committee and Risk Management Committee of the Board of Directors	23-08-09
Ipca Laboratories Acquires 33% Stake in Unichem for INR9.45 Billion	23-08-02
Unichem Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-14
Unichem Laboratories Swings to Loss in Fiscal Q4	23-05-24
Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-23
Ipca Laboratories to Acquire 33% Stake in Unichem for INR10.3 Billion	23-04-25
India's Ipca Laboratories sinks to 3-yr low after Unichem Lab deal	23-04-25
Indian pharma Ipca Labs to buy over 33% stake in Unichem	23-04-24
Sekhmet Pharmaventures Private Limited acquired 19.97% stake in Optimus Drugs Private Limited.	23-03-30
Unichem Laboratories Limited Announces Board Changes	23-03-20
Unichem Laboratories Limited Receives ANDA Approval for its Ranolazine Extended-Release Tablets, 500 Mg and 1,000 Mg from the United States Food and Drug Administration	23-03-17

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Unichem Laboratories Limited NSE India S.E.

Equities

UNICHEMLAB

INE351A01035

Other languages

Filters